Amferia AB is happy to announce the appointment of Ingvar Karlsson as the Chief Financial Officer. Ingvar has extensive background in financial management within a broad area including the life-science industry.
Ingvar has a solid background as the CFO from both public and private companies covering Life science and Medtech, Automotive and premium consumer goods spanning over 40 years. Today, he works both on the Board of cutting-edge life-science SME’s as well as provide service as CFO for their successful growth. Ingvar’s extensive knowledge in financial management, supply chain processes and capital planning of life science companies, will be important for Amferia’s scale-up journey in both human and animal wound care.
Anand Kumar Rajasekharan, CEO of Amferia − “It is an honour to work with Ingvar, whose impressive knowledge of the field and guidance greatly strengthens Amferia’s position as a competent and cutting-edge SME with precision in its numbers. We look forward to jointly grow the company, as we set our sights on global growth of Amferia both in human and animal wound care.
Ingvar Karlsson, CFO of Amferia − “I look forward working with the team at Amferia. The company has a very interesting journey ahead. Amferia is en route towards internationalization and distribution of its products through partnerships in multiple countries. I am glad to work with companies like Amferia improving healthcare for both humans and animals. ”
